Device-tax repeal will keep U.S. edge in global medtech, exec says

03/27/2013 | Hill, The

The industry already has paid the Internal Revenue Service about $388 million since the 2.3% medical device tax went into effect in January, shifting funds that could be used to create jobs and advance research and development, writes Siemens Healthcare CEO Dr. Greg Sorensen. The passage of the Senate budget amendment to repeal the tax is a key step toward reversing its adverse effects and preserving U.S. leadership in the global medtech industry, he writes.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC